Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Short Interest Down 6.3% in November
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 6,500,000 shares, a decline of 6.3% from the October 31st total of 6,940,000 shares. Based on an average daily trading volume, of 713,900 shares, the days-to-cover ratio is presently […]
More Stories
Robert L. Goldstein Sells 54,000 Shares of BlackRock, Inc. (NYSE:BLK) Stock
BlackRock, Inc. (NYSE:BLK – Get Free Report) COO Robert L. Goldstein sold 54,000 shares of BlackRock stock in a transaction...
Insider Buying: Shattuck Labs, Inc. (NASDAQ:STTK) Director Acquires 133,371 Shares of Stock
Shattuck Labs, Inc. (NASDAQ:STTK – Get Free Report) Director Redmile Group, Llc bought 133,371 shares of the company’s stock in...
Kennedy-Wilson (NYSE:KW) Upgraded to Hold at StockNews.com
Kennedy-Wilson (NYSE:KW – Get Free Report) was upgraded by equities researchers at StockNews.com from a “sell” rating to a “hold”...
American Public Education (NASDAQ:APEI) Upgraded at StockNews.com
American Public Education (NASDAQ:APEI – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to...
Stratus Properties (NASDAQ:STRS) Upgraded to “Hold” at StockNews.com
Stratus Properties (NASDAQ:STRS – Get Free Report) was upgraded by stock analysts at StockNews.com from a “sell” rating to a...
Focus Impact Acquisition Corp. Issues Warrant Adjustment Notice Following Business CombinationOn December 6, 2024, Focus Impact Acquisition Corp., now known as DevvStream Corp. after completing a business combination with DevvStream Holdings Inc., ma
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...